Loading

Journal of Addiction Medicine and Therapy

Maintaining a Focus on Cognitive Function in the Treatment of Substance Use Disorders

Editorial | Open Access Volume 1 | Issue 1 |

  • 1. Department of Psychiatry, The University of Texas Southwestern Medical Center, USA
+ Show More - Show Less
Corresponding Authors
Tracy L. Greer, Department of Psychiatry, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9119, USA, Tel: (214) 648-0156; Fax: (214) 648-0167;
Citation

Greer TL (2013) Maintaining a Focus on Cognitive Function in the Treatment of Substance Use Disorders. J Addict Med Ther 1: 1001.

INTRODUCTION

Although effective treatments for substance use disorders do exist, there is certainly significant need for improvement, as many treatments only yield modest benefits. Substantial efforts are indeed underway to improve treatment outcomes for individuals with substance use disorders, with cognitive function receiving increased attention in this regard. Cognitive impairments are recognized as both a potential risk factor of addiction, as well as a consequence of long-term substance use, providing a variety of potential treatment targets.

Cognitive impairments have been associated with a variety of poor treatment outcomes in individuals with substance use disorders [1]. For example, both self-report and behavioral tasks measuring impulsivity have shown that individuals with substance dependence are more impulsive in comparison to healthy controls [2,3], and higher impulsivity in turn has been associated with an increased risk for relapse [4]. Substance dependent individuals also show an attentional bias for substance-related cues, which has been at least moderately associated with increased craving, quantity and frequency of use [5,6]; however, results of studies to date have been mixed, with some suggesting no association. Furthermore, activation in dorsal anterior cingulate cortex associated with attentional bias significantly predicted cocaine relapse in a recent study [7], and therefore might be considered as a biomarker of relapse vulnerability. Evidence suggests that impulsivity and attentional bias are related, and it has been hypothesized that dopaminergic alterations associated with impulsivity affect key brain regions involved in attentional biases that may result in an increased likelihood of substance-cued attentional bias and an increased association between substance cues and attention through classical conditioning processes [8]. In fact, Kosten et al. [9] observed greater activation in response to drug cues in sensory, motor and limbic cortices of depressed cocaine dependent patients with greater relapse and substance use during treatment compared to those who did not relapse and had less drug use during treatment. The authors suggest that activation, particularly in posterior cingulate, may facilitate a learned habit through initiation of motor responses. The authors also advocate the importance of examining changes in brain activation as a potential target of treatment development, particularly since brain activation better predicted relapse than did subjective reports of craving. The continual improvement and advancements of neuroimaging techniques should allow us to better understand the neural changes associated with cognitive impairments and potential cognitive improvements that may occur following substance use treatments and abstinence.

A variety of compounds have been investigated with the hope of improving cognitive outcomes in substance users, which would in turn be expected to improve substance use outcomes (see Brady et al. [10] and Sofuoglu et al. [11] for recent reviews). Pharmacological agents targeting glutamatergic and cholinergic systems, as well as those of the biogenic amines (e.g., histamine and the catecholamines, dopamine and norepinephrine), have been associated with at least some improvements in the cognitive function of substance users [10-12]. These agents may directly reduce drug-induced cognitive deficits, as well as diminish the rewarding or reinforcing properties of addictive substances, most often by affecting neuromodulation in hippocampal and prefrontal regions. However, additional research is clearly needed in this area, as many of the studies to date have been small pilot trials that have produced equivocal results, and few studies adequately evaluate both cognitive and substance use outcomes.

Behavioral strategies such as cognitive behavioral therapy (CBT) and cognitive remediation are also being investigated [11]. Modifications to traditional CBT, including a computerized presentation, may improve the ability for substance users with cognitive impairments to better utilize such therapy and fully realize its benefits. Cognitive remediation, which involves the repetitive practice of cognitive tasks, may also directly improve cognitive function. Other behavioral interventions, such as exercise, which is associated with cognitive improvements in many other chronic diseases, is also an area that is ripe for investigation in addicted individuals. Other nontraditional therapies also warrant further consideration for use in treating cognitive impairments in substance users. For example, a pilot trial examining the nutritional supplement, citicoline, showed improvements in verbal learning and memory in cocaine dependent individuals with bipolar disorder [13]. However, another investigation of mood-disordered individuals with methamphetamine dependence did not show cognitive improvement with citicoline, suggesting that this compound may have selective effects depending on the substance abused [14].

In addition to their potential to adversely impact substance use outcomes, cognitive impairments are increasingly becoming recognized as being associated with reduced productivity and quality of life in substance use disorders, similar to associations observed in other psychiatric disorders, such as schizophrenia and depression. This suggests a need to also evaluate the impact of cognition, and potential treatments for cognitive impairments, on measures of quality of life and functioning in addicted individuals.

The far-reaching implications of cognitive impairments associated with substance misuse indicate a need to directly treat cognitive symptoms. While the relationships between several cognitive constructs and drug use outcomes are still being fully elucidated, they hold strong potential for development of treatment modalities for substance dependent individuals to help reduce the likelihood of relapse, reduce drug use quantity and frequency, and improve quality of life. This is an exciting time in the field, as the rapid developments in neuroimaging and other technologies will be of great benefit in this area. Future research should continue to investigate this promising area by maintaining the focus on identification of both pharmacological and behavioral interventions that improve cognitive outcomes and associated substance use and functional outcomes, with the goal of ultimately improving the care and quality of life of individuals with substance use disorders.

CONFLICTS OF INTEREST

Dr. Greer has received research funding from NARSAD and consulting fees from H. Lundbeck A/S and Takeda Phamaceutical International, Inc.

REFERENCES

1. McKellar JD, Harris AH, Moos RH. Predictors of outcome for patients with substance-use disorders five years after treatment dropout. J Stud Alcohol. 2006; 67: 685-93.

2. Allen TJ, Moeller FG, Rhoades HM, Cherek DR. Impulsivity and history of drug dependence. Drug Alcohol Depend. 1998; 50: 137-45.

3. Lillis J, Levin ME, Trafton JA. Elevated BMI and illicit drug use are associated with decreased ability to inhibit prepotent behaviors. Addict Behav. 2012; 37: 544-7.

4. Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology. 2010; 35: 217-38.

5. Field M, Cox WM. Attentional bias in addictive behaviors: a review of its development, causes, and consequences. Drug Alcohol Depend. 2008; 97: 1-20.

6. Field M, Munafò MR, Franken IH. A meta-analytic investigation of the relationship between attentional bias and subjective craving in substance abuse. Psychol Bull. 2009; 135: 589-607.

7. Marhe R, Luijten M, van de Wetering BJ, Smits M, Franken IH. Individual differences in anterior cingulate activation associated with attentional bias predict cocaine use after treatment. Neuropsychopharmacology. 2013; 38: 1085-93.

8. Coskunpinar A, Cyders MA. Impulsivity and substance-related attentional bias: A meta-analytic review. Drug Alcohol Depend. 2013 Jun 6. [Epub ahead of print]

9. Kosten TR, Scanley BE, Tucker KA, Oliveto A, Prince C, Sinha R, Potenza MN, Skudlarski P, Wexler BE. Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology. 2006; 31: 644-50.

10. Brady KT, Gray KM, Tolliver BK. Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol Biochem Behav. 2011; 99: 285-94.

11. Sofuoglu M, DeVito EE, Waters AJ, Carroll KM. Cognitive enhancement as a treatment for drug addictions. Neuropharmacology. 2013; 64: 452-63.

12. Alleva L, Tirelli E, Brabant C. Therapeutic potential of histaminergic compounds in the treatment of addiction and drug-related cognitive disorders. Behav Brain Res. 2013; 237: 357-68.

13. Brown ES, Gorman AR, Hynan LS. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence. J Clin Psychopharmacol. 2007; 27: 498-502.

14. Brown ES, Gabrielson B. A randomized, double-blind, placebo-controlled trial of citicoline for bipolar and unipolar depression and methamphetamine dependence. J Affect Disord. 2012; 143: 257-60.

Greer TL (2013) Maintaining a Focus on Cognitive Function in the Treatment of Substance Use Disorders. J Addict Med Ther 1: 1001.

Received : 22 Jul 2013
Accepted : 21 Aug 2013
Published : 26 Aug 2013
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X